Novavax prices stock offering

Novavax (NVAX) prices its public offering of 25M shares of common stock at $4.00 per share. Underwriters over-allotment is 3.75M shares. Net proceeds of ~$94M will be used for general corporate purposes, the advancement of its clinical-stage vaccine candidates, its preclinical research programs, manufacturing and process development activities, CAPEX and other strategic purposes. Closing date is June 11.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs